New eye drop trial aims to soothe chronic dry eye sufferers
NCT ID NCT07224529
First seen Nov 05, 2025 · Last updated May 09, 2026 · Updated 22 times
Summary
This study tests whether Vevye eye drops (cyclosporine 0.1%) can improve symptoms and signs of meibomian gland dysfunction (MGD), a common cause of dry, burning eyes. About 48 adults with moderate-to-severe MGD will use the drops twice daily for 24 weeks. Researchers will measure changes in gland function, dryness, and eye surface health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEIBOMIAN GLAND DYSFUNCTION (MGD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham, School of Optometry, Clinical Eye Research Facility
Birmingham, Alabama, 35294, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.